Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Neo7Bioscience Takes the Lead in Collaboration with Serokell and Knowledge Graph Developer Elsevier to Revolutionize Molecular Research and Peptide Engineering for Precision and Personalized Medicine

April 15, 2024 at 07:00 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Neo7Bioscience, at the forefront of molecular research, assumes a pivotal role in a transformative collaboration with Serokell, a leading AI development company, and Elsevier, the developer of the knowledge graph and a leading provider of scientific knowledge. This strategic alliance aims to revolutionize bioinformatics, molecular target analysis, and peptide engineering, focusing on advancing precision and personalized medicine.

Neo7Bioscience, leveraging its profound expertise in molecular analytics and peptide engineering, spearheads the path for revolutionary breakthroughs in personalized therapeutics. Serokell, recognized for its excellence in crafting customized high-performance solutions, complements Neo7Bioscience's vision by enhancing the computational aspects of the research.

"We are thrilled to lead this collaboration with Serokell and Elsevier,” said John A. Catanzaro, CEO at Neo7Bioscience. "By combining our deep knowledge of molecular analytics and peptide engineering with cutting-edge software development, we aim to reshape the landscape of precision and personalized medicine for the benefit of patients globally."

Serokell's precision data solutions align seamlessly with Neo7Bioscience's mission, bolstering molecular research efficiency. Ivan Smetannikov, Serokell's Head of Data Science and ML, and Alexey Khachiyants, Data Scientist and ML engineer, emphasize the transformative influence of integrating data architecture expertise into advancing precision and personalized medicine.

Elsevier, the developer of the knowledge graph, is a key partner in this endeavor, integrating the combined efforts of Neo7Bioscience and Serokell into its knowledge graph bioinformatics platform. This collaboration creates a holistic data analysis and interpretation approach, as emphasized by Anton Yuryev, Consulting Director of Bioinformatics and Data Science at Elsevier.

Neo7Bioscience, Serokell, and Elsevier are poised to revolutionize the molecular research and peptide engineering landscape, ushering in more efficient and tailored solutions for precision and personalized medicine.